skip to content

Department of Oncology

 
Read more at: Jamie Blundell named as UKRI Future Leaders Fellow

Jamie Blundell named as UKRI Future Leaders Fellow

7 November 2019

Congratulations to Jamie Blundell (Oncology, CRUK Cambridge Centre Early Detection Programme) who has been awarded a £1.2 million Future Leaders Fellowship by UK Research and Innovation (UKRI). The fellowship will enable Jamie to build a team in the CRUK Cambridge Centre Early Detection Programme , with the aim of...


Read more at: Charlotte Coles appointed as new Deputy Head of Department

Charlotte Coles appointed as new Deputy Head of Department

7 November 2019

Congratulations to Charlotte Coles (Oncology and CRUK Cambridge Centre) on her appointment as Deputy Head of the Department of Oncology. Charlotte is a National Institute of Health Research (NIHR) Research Professor and Reader in Breast Radiation Oncology. Her research aims to provide breast cancer patients with the best...


Read more at: £5.6M boost for children’s brain tumour research

£5.6M boost for children’s brain tumour research

6 August 2019

Cancer Research UK has awarded Professor Richard Gilbertson (Oncology, CRUK Cambridge Centre & Cancer Research UK Cambridge Institute) £5.86 million to lead an international team focussing on gaining a better understanding of the biology of children’s brain tumours, with the future aim of developing much needed new...


Read more at: New findings shed light on treating advanced breast cancer

New findings shed light on treating advanced breast cancer

6 August 2019

Researchers from the Cancer Research UK Cambridge Institute and Cancer Research UK Cambridge Centre, led by Professor Carlos Caldas (CRUK CI, Oncology), have discovered that advanced breast cancer probably spreads in waves rather than continuously. The team collected 181 tumours during post mortem examinations on 10 women...


Read more at: Halving treatment for HER2+ early breast cancer patients

Halving treatment for HER2+ early breast cancer patients

6 August 2019

The PERSEPHONE trial, led by Professor Helena Earl (Oncology and CRUK Cambridge Centre), recruited over 4,000 women with HER2 positive early breast cancer to establish the outcomes of shortening the duration of treatment. This £2.6 million study funded by the (National Institute for Health Research (NIHR) with...


Read more at: Clinical trial offers experimental cancer treatment to patients with the same genetic mutations

Clinical trial offers experimental cancer treatment to patients with the same genetic mutations

12 March 2019

A new type of experimental trial, the Basket of Baskets trial has just launched in Cambridge to treat patients with different types of cancer with the same targeted therapy. The trial uses a common molecular profiling platform to allocate patients to targeted therapies, based on the genetic features of their individual...


Read more at: Early diagnosis prize

Early diagnosis prize

11 February 2019

Professor Rebecca Fitzgerald receives the prestigious 'Jane Wardle Prevention and Early Diagnosis' prize from Iain Foulkes, Executive Director of Research and Innovation at Cancer Research UK/CEO of Cancer Research Technology. This prestigious prize recognises individuals who have produced world-leading research in the...


Read more at: Clinical trial launches to develop breath test for multiple cancers

Clinical trial launches to develop breath test for multiple cancers

11 February 2019

Professor Rebecca Fitzgerald , Department of Oncology, MRC Cancer Unit and co-lead of the CRUK Cambridge Centre Early Detection Programme is leading a new clinical trial at Addenbrooke’s Hospital to develop a breath test that could indicate the presence of multiple cancer types at an early stage. This is the first test of...


Read more at: Mapping oesophageal cancer genes leads to new drug targets

Mapping oesophageal cancer genes leads to new drug targets

11 February 2019

Professor Rebecca Fitzgerald , Department of Oncology, MRC Cancer Unit and co-lead of the CRUK Cambridge Centre Early Detection Programme is the lead researcher of a recent study that identified mutations responsible for oesophageal adenocarcinoma (OAC), using a combination of whole genome sequencing and whole exome...


Read more at: Professor Anna Philpott receives the '2018 Anne McLaren Outstanding Women in Developmental Biology Award'

Professor Anna Philpott receives the '2018 Anne McLaren Outstanding Women in Developmental Biology Award'

23 October 2018

Congratulations to Professor Anna Philpott who has received the ‘2018 Anne McLaren Award for Outstanding Women in Developmental Biology' from the International Society of Differentiation (ISD). Professor Philpott accepted her award at the CamBio2018 Conference, a major biennial conference organised jointly by the ISD and...